ArticleJournal of clinical medicine2026

Promoter Methylation and Somatic Mutations in Cancer-Related Genes Are Associated with Hyperprogressive Disease in Patients with Malignant Melanoma and Renal Cell Carcinoma Receiving Anti-PD-1/PD-L1 Immunotherapy.

Adem Deligonul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.